勘误：用于治疗导管相关尿路感染及相关生物被膜的噬菌体鸡尾酒疗法的研发
Corrigendum: Development of phage cocktails to treat catheter-associated urinary tract infection and associated biofilms.
作者信息
Sanchez Belkys C, Heckmann Emmaline R, Green Sabrina I, Clark Justin R, Kaplan Heidi B, Ramig Robert F, Muldrew Kenneth L, Hines-Munson Casey, Skelton Felicia, Trautner Barbara W, Maresso Anthony W
机构信息
Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States.
Department of Microbiology and Molecular Genetics, McGovern Medical School, UTHealth Houston, Houston, TX, United States.
出版信息
Front Microbiol. 2022 Aug 9;13:953136. doi: 10.3389/fmicb.2022.953136. eCollection 2022.
Abstract
[This corrects the article DOI: 10.3389/fmicb.2022.796132.].
摘要
[本文更正了文章DOI：10.3389/fmicb.2022.796132。]
相似文献
1
Corrigendum: Development of phage cocktails to treat catheter-associated urinary tract infection and associated biofilms.勘误：用于治疗导管相关尿路感染及相关生物被膜的噬菌体鸡尾酒疗法的研发
Front Microbiol. 2022 Aug 9;13:953136. doi: 10.3389/fmicb.2022.953136. eCollection 2022.
2
Development of Phage Cocktails to Treat Catheter-Associated Urinary Tract Infection and Associated Biofilms.用于治疗导管相关性尿路感染及相关生物被膜的噬菌体鸡尾酒疗法的开发。
Front Microbiol. 2022 May 10;13:796132. doi: 10.3389/fmicb.2022.796132. eCollection 2022.
3
Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic Isolates, India.噬菌体590B对印度多重耐药和广泛耐药尿路致病性分离株的基因组分析及抗生物膜活性
Pathogens. 2022 Nov 30;11(12):1448. doi: 10.3390/pathogens11121448.
4
Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.使用多价噬菌体来对抗导致导管相关性尿路感染的奇异变形杆菌生物膜。
J Appl Microbiol. 2018 Nov;125(5):1253-1265. doi: 10.1111/jam.14026. Epub 2018 Jul 18.
5
Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.组合小分子疗法可预防小鼠尿路致病性大肠埃希菌引起的导管相关性尿路感染。
Antimicrob Agents Chemother. 2012 Sep;56(9):4738-45. doi: 10.1128/AAC.00447-12. Epub 2012 Jun 25.
6
Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India.一种新型噬菌体vB_EcoA_RDN8.1的特性、基因组分析及其对印度多药耐药和广泛耐药的形成生物膜的尿路致病性大肠杆菌分离株的体外活性
J Appl Microbiol. 2022 Apr;132(4):3387-3404. doi: 10.1111/jam.15439. Epub 2022 Jan 17.
7
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.噬菌体抗性伴随尿路致病性大肠埃希菌在尿路环境中适应性降低。
mSphere. 2022 Aug 31;7(4):e0034522. doi: 10.1128/msphere.00345-22. Epub 2022 Aug 3.
8
Anti-Biofilm Effect of Bacteriophages and Antibiotics against Uropathogenic .噬菌体和抗生素对尿路致病性细菌的抗生物膜作用
Antibiotics (Basel). 2022 Nov 26;11(12):1706. doi: 10.3390/antibiotics11121706.
9
Disperse red 15 (DR15) impedes biofilm formation of uropathogenic Escherichia coli.分散红 15（DR15）可抑制尿路致病性大肠埃希菌生物膜的形成。
Microb Pathog. 2020 Jan;138:103772. doi: 10.1016/j.micpath.2019.103772. Epub 2019 Oct 4.
10
Coating of silicone with mannoside-PAMAM dendrimers to enhance formation of non-pathogenic Escherichia coli biofilms against colonization of uropathogens.用甘露糖苷-PAMAM树枝状大分子包覆硅胶，以增强非致病性大肠杆菌生物膜的形成，抵御尿路致病菌的定植。
Acta Biomater. 2017 Dec;64:200-210. doi: 10.1016/j.actbio.2017.10.008. Epub 2017 Oct 9.
引用本文的文献
1
The rise, fall, and resurgence of phage therapy for urinary tract infection.用于治疗尿路感染的噬菌体疗法的兴衰与复兴
EcoSal Plus. 2024 Dec 12;12(1):eesp00292023. doi: 10.1128/ecosalplus.esp-0029-2023. Epub 2024 Jan 11.
2
Phage Therapy-Challenges, Opportunities and Future Prospects.噬菌体疗法——挑战、机遇与未来前景
Pharmaceuticals (Basel). 2023 Nov 22;16(12):1638. doi: 10.3390/ph16121638.
Zotero 插件